ebastin orifarm 10 mg
orifarm generics a/s - ebastin - tablett, filmdrasjert - 10 mg
ebastin orifarm 20 mg
orifarm generics a/s - ebastin - tablett, filmdrasjert - 20 mg
zilas 20 mg
menarini international o.l. sa - bilastin - tablett - 20 mg
kestine 20 mg
almirall, s.a. - ebastin - tablett, filmdrasjert - 20 mg
kestine 10 mg
almirall, s.a. - ebastin - tablett, filmdrasjert - 10 mg
kestine 10 mg
2care4 aps - ebastin - tablett, filmdrasjert - 10 mg
kestine 20 mg
2care4 aps - ebastin - tablett, filmdrasjert - 20 mg
breyanzi
bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastiske midler - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.
yescarta
kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastiske midler - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.
sporanox 100 mg
janssen-cilag as - itrakonazol - kapsel, hard - 100 mg